 |
 |
 |
 |
 |
 |
|||
 | ||||||
| LATISSE™ | |
Hypotrichosis of the Eyelashes | |
United States | |
2008 |
| ||||||
| TRIVARIS™ | |
Retinal Disease | |
United States | |
2008 |
| ||||||
| BOTOX® | |
Post-Stroke Upper Limb Spasticity | |
Korea | |
2008 |
| ||||||
| BOTOX® | |
Glabellar Lines | |
Korea | |
2008 |
| ||||||
| BOTOX® | |
Severe Primary Axillary Hyperhidrosis | |
Korea | |
2008 |
| ||||||
| BOTOX® | |
Upper Limb Spasticity Associated with Juvenile Cerebral Palsy | |
Australia | |
2008 |
| ||||||
| JUVÉDERM® Ultra and Ultra Plus with lidocaine |
|
Facial Aesthetics | |
Canada, Australia | |
2008 |
| ||||||
| VOLUMA™ | |
Facial Aesthetics | |
Australia, Europe, Canada | |
2008 |
| ||||||
| BOTOX® | |
Neurogenic Overactive Bladder | |
Brazil | |
2009 |
| ||||||
| BOTOX® | |
Glabellar Lines | |
China* | |
2009 |
| ||||||
| BOTOX® | |
Juvenile Cerebral Palsy | |
Japan* | |
2009 |
| ||||||
| BOTOX VISTA® | |
Glabellar Lines | |
Japan* | |
2009 |
| ||||||
|
|
|
||
| ||||
| BOTOX® | |
Post-Stroke Upper Limb Spasticity | |
United States |
| ||||
| JUVÉDERM® Ultra and Ultra Plus with lidocaine | |
Facial Aesthetics | |
United States |
| ||||
| Natrelle® Style 410 | |
Breast Reconstruction & Augmentation | |
United States |
| ||||
| ACULAR® X | |
Inflammation | |
United States |
| ||||
| POSURDEX® | |
Macular Edema Associated with Retinal Vein Occlusion | |
United States |
| ||||
| LUMIGAN® X | |
Intraocular Pressure/Glaucoma | |
United States |
| ||||
| LUMIGAN® | |
Intraocular Pressure/Glaucoma | |
Japan** |
| ||||
| * | Through partnership with GlaxoSmithKline in Japan and China. | |
| ** | Through partnership with Senju Pharmaceutical Company, Ltd. in Japan. |